ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 124 filers reported holding ANAPTYSBIO INC in Q1 2021. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $179,995 | -12.1% | 10,022 | -0.4% | 0.00% | – |
Q2 2023 | $204,762 | -63.9% | 10,067 | -45.0% | 0.00% | – |
Q4 2022 | $567,024 | +21.4% | 18,297 | -0.1% | 0.00% | – |
Q3 2022 | $467,000 | +21.6% | 18,313 | -3.4% | 0.00% | – |
Q2 2022 | $384,000 | -7.0% | 18,949 | +13.5% | 0.00% | – |
Q1 2022 | $413,000 | -38.2% | 16,698 | -13.1% | 0.00% | – |
Q4 2021 | $668,000 | +16.0% | 19,214 | -9.6% | 0.00% | – |
Q3 2021 | $576,000 | +10.6% | 21,255 | +5.8% | 0.00% | – |
Q2 2021 | $521,000 | +29.0% | 20,083 | +7.1% | 0.00% | – |
Q1 2021 | $404,000 | -35.2% | 18,753 | -35.3% | 0.00% | – |
Q4 2020 | $623,000 | +59.7% | 28,986 | +9.6% | 0.00% | – |
Q3 2020 | $390,000 | -35.9% | 26,439 | -2.8% | 0.00% | – |
Q2 2020 | $608,000 | +42.4% | 27,209 | -10.1% | 0.00% | – |
Q1 2020 | $427,000 | -96.4% | 30,260 | -91.1% | 0.00% | -100.0% |
Q3 2019 | $11,951,000 | -80.7% | 341,563 | -68.9% | 0.00% | -81.2% |
Q2 2019 | $61,919,000 | +19310.3% | 1,097,462 | +25030.8% | 0.02% | – |
Q1 2019 | $319,000 | -94.4% | 4,367 | -94.6% | 0.00% | -100.0% |
Q2 2018 | $5,696,000 | -14.2% | 80,176 | +25.7% | 0.00% | 0.0% |
Q1 2018 | $6,639,000 | -15.1% | 63,787 | -17.8% | 0.00% | -33.3% |
Q4 2017 | $7,818,000 | – | 77,623 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 3,688,448 | $102,354,000 | 54.68% |
Novo Holdings A/S | 3,033,504 | $84,180,000 | 8.96% |
BVF INC/IL | 1,738,600 | $48,246,000 | 8.21% |
Cormorant Asset Management, LP | 895,626 | $24,854,000 | 3.61% |
Perceptive Advisors | 881,957 | $24,474,000 | 1.39% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 100,500 | $2,789,000 | 1.07% |
ACUTA CAPITAL PARTNERS, LLC | 165,690 | $4,138,000 | 0.98% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,746 | $23,469,000 | 0.90% |
Iguana Healthcare Management, LLC | 50,000 | $1,388,000 | 0.69% |
Boxer Capital, LLC | 50,000 | $1,388,000 | 0.30% |